Bioiasis AD (BIOA) Stock Overview

Bioiasis PLC is a Bulgarian company that specializes in providing high-quality medical devices. More details

BIOA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	1/6
Financial Health	1/6
Dividends	0/6

Risk Analysis

Debt is not well covered by operating cash flow

Shares are highly illiquid

Makes less than USD$1m in revenue (€12K)

Does not have a meaningful market cap (€10M)

+ 1 more risk

BIOA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW494,271 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

494,271 investors already sharing narratives

View all narratives

Bioiasis AD Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bioiasis AD
Historical stock prices
Current Share Price	€8.25
52 Week High	€8.25
52 Week Low	€8.25
Beta	-0.00098
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-49.26%

Recent updates

Shareholder Returns

	BIOA	BG Healthcare	BG Market
7D	0%	0.9%	-0.6%
1Y	n/a	-1.6%	13.3%

Return vs Industry: Insufficient data to determine how BIOA performed against the BG Healthcare industry.

Return vs Market: Insufficient data to determine how BIOA performed against the BG Market.

Price Volatility

Is BIOA's price volatile compared to industry and market?
BIOA volatility
BIOA Average Weekly Movement	n/a
Healthcare Industry Average Movement	4.8%
Market Average Movement	5.1%
10% most volatile stocks in BG Market	8.1%
10% least volatile stocks in BG Market	2.8%

Stable Share Price: BIOA's share price has been volatile over the past 3 months compared to the BG market.

Volatility Over Time: Insufficient data to determine BIOA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2005	1	Deyan Bratkov	www.bioiasis.com

Bioiasis PLC is a Bulgarian company that specializes in providing high-quality medical devices. They are listed on the Bulgarian Stock Exchange under the ticker symbol Bioiasis and have been recognized by international financial media such as Bloomberg Businessweek and the Financial Times.

Bioiasis AD Fundamentals Summary

How do Bioiasis AD's earnings and revenue compare to its market cap?
BIOA fundamental statistics
Market cap	€9.66m
Earnings (TTM)	€61.34k
Revenue (TTM)	€12.00k

157.5x

P/E Ratio

805.2x

P/S Ratio

Is BIOA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOA income statement (TTM)
Revenue	€12.00k
Cost of Revenue	€0
Gross Profit	€12.00k
Other Expenses	-€49.34k
Earnings	€61.34k

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	0.052
Gross Margin	100.00%
Net Profit Margin	511.17%
Debt/Equity Ratio	8,146.6%

How did BIOA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/21 03:09
End of Day Share Price	2026/05/29 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bioiasis AD is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Bioiasis ADBUL:BIOA Stock Report